{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:22:12Z","timestamp":1788009732150,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP- 49462"],"award-info":[{"award-number":["MOP- 49462"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["94480"],"award-info":[{"award-number":["94480"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.chest.2019.11.007","type":"journal-article","created":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T20:05:55Z","timestamp":1574366755000},"page":"846-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD"],"prefix":"10.1016","volume":"157","author":[{"given":"Samy","family":"Suissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Dell\u2019Aniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"9859","key":"10.1016\/j.chest.2019.11.007_bib2","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2019.11.007_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00214-2017","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD Executive Summary","volume":"49","author":"Vogelmeier","year":"2017","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2019.11.007_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.00128914","article-title":"Inhaled corticosteroids in COPD: the clinical evidence","volume":"45","author":"Ernst","year":"2015","journal-title":"Eur Respir J"},{"issue":"10125","key":"10.1016\/j.chest.2019.11.007_bib6","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/S0140-6736(18)30206-X","article-title":"Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial","volume":"391","author":"Papi","year":"2018","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.chest.2019.11.007_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-daily single-inhaler triple versus\u00a0dual therapy in patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.chest.2019.11.007_bib8","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMe1716802","article-title":"Making sense of triple inhaled therapy for COPD","volume":"378","author":"Suissa","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01848-2018","article-title":"Triple therapy trials in COPD: a precision medicine opportunity","volume":"52","author":"Suissa","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib10","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1056\/NEJMc1807380","article-title":"Single-inhaler triple versus dual therapy in patients with COPD","volume":"379","author":"Wedzicha","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01586-2018","article-title":"Triple therapy versus single and dual long-acting bronchodilator therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"52","author":"Cazzola","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.11.007_bib12","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1378\/chest.11-0038","article-title":"The impact of tiotropium on mortality and exacerbations when added to inhaled corticosteroids and long-acting beta2-agonist therapy in COPD","volume":"141","author":"Short","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib13","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00408-014-9611-8","article-title":"Impact of long-acting bronchodilators and exposure to inhaled corticosteroids on mortality in COPD: a real-life retrospective cohort study","volume":"192","author":"Manoharan","year":"2014","journal-title":"Lung"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1592\/phco.23.5.686.32205","article-title":"Validity of the general practice research database","volume":"23","author":"Jick","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.chest.2019.11.007_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the general practice research database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.chest.2019.11.007_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib17","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.chest.2019.03.005","article-title":"Comparative effectiveness and safety of LABA-LAMA vs\u00a0LABA-ICS treatment of COPD in real-world clinical practice","volume":"155","author":"Suissa","year":"2019","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.chest.2019.11.007_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/pds.4107","article-title":"Prevalent new-user cohort designs for comparative drug effect studies by time-conditional propensity scores","volume":"26","author":"Suissa","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"10.1016\/j.chest.2019.11.007_bib19","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02245-2016","article-title":"Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events","volume":"49","author":"Suissa","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.11.007_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.chest.2016.08.001","article-title":"Long-acting bronchodilator initiation in COPD and the risk of adverse cardiopulmonary events","volume":"151","author":"Suissa","year":"2017","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.chest.2019.11.007_bib22","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(18)30368-0","article-title":"Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study","volume":"6","author":"Suissa","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2019.11.007_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151357","article-title":"Validation of the recording of acute exacerbations of COPD in UK primary care electronic healthcare records","volume":"11","author":"Rothnie","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.chest.2019.11.007_bib24","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2147\/CLEP.S117867","article-title":"Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records","volume":"8","author":"Rothnie","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib25","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/pds.3207","article-title":"Accuracy of pneumonia hospital admissions in a primary care electronic medical record database","volume":"21","author":"Meropol","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.chest.2019.11.007_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1093\/aje\/kwr364","article-title":"Effects of adjusting for instrumental variables on bias and precision of effect estimates","volume":"174","author":"Myers","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00361-2017","article-title":"Run-in bias in randomised trials: the case of COPD medications","volume":"49","author":"Suissa","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2019.11.007_bib29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/thoraxjnl-2015-207021","article-title":"Blood eosinophils and inhaled corticosteroid\/long-acting beta-2 agonist efficacy in COPD","volume":"71","author":"Pavord","year":"2016","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"9","key":"10.1016\/j.chest.2019.11.007_bib31","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment. Data from the FLAME Trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2019.11.007_bib32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S2213-2600(15)00145-9","article-title":"Targeted therapy with inhaled corticosteroids in COPD according to blood eosinophil counts","volume":"3","author":"Brusselle","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-2600(16)30040-6","article-title":"Serum eosinophils as a COPD biomarker: Ready for prime time?","volume":"4","author":"Iyer","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2019.11.007_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chest.2017.05.020","article-title":"Precision medicine urgency: the case of inhaled corticosteroids in COPD","volume":"152","author":"Suissa","year":"2017","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2019.11.007_bib35","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.chest.2018.04.006","article-title":"Observational studies of inhaled corticosteroid effectiveness in copd: lessons learned","volume":"154","author":"Suissa","year":"2018","journal-title":"Chest"},{"issue":"10082","key":"10.1016\/j.chest.2019.11.007_bib36","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(17)30188-5","article-title":"Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial","volume":"389","author":"Vestbo","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.chest.2019.11.007_bib37","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1378\/chest.15-0627","article-title":"Discontinuation of inhaled corticosteroids in COPD and the risk reduction of pneumonia","volume":"148","author":"Suissa","year":"2015","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2019.11.007_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1164\/rccm.200611-1630OC","article-title":"Inhaled corticosteroid use in chronic obstructive pulmonary\u00a0disease and the risk of hospitalization for pneumonia","volume":"176","author":"Ernst","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.chest.2019.11.007_bib39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.chest.2019.11.007_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005540","article-title":"Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD)","volume":"4","author":"Quint","year":"2014","journal-title":"BMJ Open"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219342254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219342254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:43:30Z","timestamp":1777409010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219342254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0012369219342254"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.11.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736978907.793567841","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative Effects of LAMA-LABA-ICS vs LAMA-LABA for COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}